磷霉素联合加替沙星注射液治疗肺结核合并下呼吸道感染的效果观察

来源:用户上传      作者:李冶

　　[摘要] 目的 分析磷霉素c加替沙星联用治疗肺结核合并下呼吸道感染的疗效。 方法 在我院2019年1月至2020年4月诊治的肺结核合并下呼吸道感染患者中选出142例为研究对象，采用随机数字表法分为对照组与试验组，每组各71例，对照组应用抗痨化疗和加替沙星治疗，试验组加用磷霉素治疗，比较两组的总有效率、血清炎症细胞因子水平、临床症状缓解时间及不良反应发生率。 结果 两组的总有效率比较，差异有统计学意义（P<0.05）;试验组治疗2周后的血清PCT、IL-6、CRP水平均低于对照组，差异有统计学意义（P<0.05）;试验组的临床症状消失时间（发热、咳嗽咳痰、肺部湿音）均短于对照组，差异有统计学意义（P<0.05）;两组不良反应总发生率比较，差异无统计学意义（P>0.05）。 结论 加替沙星联合磷霉素配合抗痨化疗方案用于肺结核合并下呼吸道感染治疗中效果肯定，有助于促进患者感染症状缓解，降低炎症反应，疗效可靠安全。
　　[关键词] 磷霉素;加替沙星;肺结核;下呼吸道感染;炎症反应;不良反应
　　[中图分类号] R521 [文献标识码] A [文章编号] 1673-9701（2021）35-0016-04
　　Observation on the efficacy of fosfomycin combined with gatifloxacin injection on pulmonary tuberculosis complicated with lower respiratory tract infection
　　LI Ye
　　Integrated Lung Cancer Center， Shenyang Tenth People′s Hospital， Shenyang 110044， China
　　[Abstract] Objective To investigate the efficacy of fosfomycin combined with gatifloxacin on pulmonary tuberculosis complicated with lower respiratory tract infection. Methods A total of 142 patients with pulmonary tuberculosis complicated with lower respiratory tract infection treated in our hospital from January 2019 to April 2020 were selected as the study objects， and they were divided into the control group （n=71） and the experimental group （n=71） according to the random number table method. The control group was treated with conventional antituberculosis chemotherapy combined with gatifloxacin， while the experimental group was treated with fosfomycin on the basis of the control group. The total effective rate， serum inflammatory cytokines levels， clinical symptom relief time and incidence of adverse reactions were compared between the two groups. Results The total effective rate of the two groups was significantly different （P<0.05）. After 2 weeks of treatment， the levels of serum PCT， IL-6 and CRP in the experimental group were all lower than those in the control group，the difference was statistically significant （P<0.05）. The recovery time of body temperature， disappearance time of cough and expectoration， disappearance time of pulmonary moist rales in patients of the experimental group were all shorter than those of the control group，the difference was statistically significant （P<0.05）. There was no significant difference in the total incidence of adverse reactions between two groups （P>0.05）. Conclusion The application of fosfomycin combined with gatifloxacin injection in patients with pulmonary tuberculosis complicated with lower respiratory tract infection is effective， which is conducive to relieving the symptoms of infection and inflammatory reaction. Meanwhile， the combined medication is highly safe and worthy of promotion.
转载注明来源:https://www.xzbu.com/6/view-15423310.htm